QNTA - Quanta, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2811
-0.0389 (-12.16%)
As of 2:15PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.3200
Open0.3110
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2811 - 0.4410
52 Week Range0.2811 - 19.0000
Volume24,959
Avg. Volume19,957
Market Cap11.757M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire

    Quanta Announces Successful Q2 Sales Growth of Flagship Polarized Products

    LOS ANGELES , Aug. 23, 2019 /PRNewswire/ -- Quanta, Inc. (OTC: QNTA), an applied science company, focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance ...

  • PR Newswire

    Quanta Partners with Influential Pharmacy Distribution and Marketing Company PharmaLynk

    LOS ANGELES, July 31, 2019 /PRNewswire/ -- Quanta Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that it has partnered with PharmaLynk. PharmaLynk is known for their distribution of unique and effective health products through their existing network to over 1000+ independent pharmacies nationwide.

  • PR Newswire

    Quanta announces Annabelle Manalo, PhD will join its board of advisors

    LOS ANGELES, July 9, 2019 /PRNewswire/ -- Quanta, Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that Annabelle Manalo, PhD will join their board of advisors to help lead innovation from within its team of expert scientists. Annabelle Dr. Manalo is a mother of four, a scientist, an educator and a respected thought leader. She is a cell and developmental biologist from Vanderbilt University in Nashville, Tennessee with a background in neuroscience from Georgetown University.

  • PR Newswire

    Polarization Technology Increases CBD's Ability to Reduce Inflammation by More Than 500%

    LOS ANGELES, July 2, 2019 /PRNewswire/ -- Quanta, Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that they released a new white paper "CBD in the Quantum Era - Polarization and its effects on anti-inflammatory abilities of cannabidiol (CBD)" which shows that Quanta's patented polarization technology increases the effectiveness of CBD to inhibit the COX 2 enzyme by 572%. In other words, the polarization process greatly increases the ability of CBD to reduce inflammation. Quanta's proprietary technology uses quantum mechanics to increase the bio-activity of targeted molecules which enhances the desired effect.

  • PR Newswire

    Dr. Arthur Mikaelian, becomes Quanta's Chief Science Officer and is named to the Board of Directors

    Dr. Arthur Mikaelian will be focused on leading Quanta's science team in further enhancing the quality of all Quanta products by increasing the bioactivity of all ingredients used in Quanta formulations.

  • PR Newswire

    Quanta Partners with Online Powerhouse Kapno

    LOS ANGELES , June 11, 2019 /PRNewswire/ -- Quanta, Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance ...

  • PR Newswire

    Quanta Partners with Skogen's Festival Foods Grocery Stores

    LOS ANGELES , June 7, 2019 /PRNewswire/ -- Quanta Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within ...

  • PR Newswire

    Quanta Inc. Announces LOI with Global Cannabinoids for Exclusive Nationwide Wholesale and Licensing Agreement

    LOS ANGELES , June 4, 2019 /PRNewswire/ -- Quanta Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within ...

  • PR Newswire

    Quanta Provides Update on Recent Success of CBD Muscle Rub Sales

    Product sales have increased 70% month over month since its launch, 5 months ago LOS ANGELES , Feb. 5, 2019 /PRNewswire/ -- Quanta, Inc. (OTC PINK: QNTA) an applied science company, focused on enhancing ...

  • ACCESSWIRE

    Quanta Launches Proprietary Polarized CBD Product Lines

    LOS ANGELES, CA / ACCESSWIRE / January 10, 2019 / Quanta, Inc. (OTC PINK: QNTA) an applied science company, focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, today announced that it will begin manufacturing its own line of polarized cannabidiol (CBD) products due to recent passage of the 2018 Farm Bill. Quanta will continue its previously agreed upon licensing arrangement with THC manufacturers.